세계의 중심 정맥 카테터 시장 규모는 2023년에 27억 3,000만 달러, 2030년까지 40억 4,000만 달러에 달하며, 2024-2030년의 예측 기간에 CAGR로 6.85%의 성장이 전망됩니다. 시장은 암, 심혈관질환, 신장병 등의 만성질환의 유병률 증가, 좌식 생활방식의 증가, 수혈의 증가, 제품에 관한 기술의 진보 등의 요인에 의해 호황을 나타낼 전망이며, 예측 기간(2024-2030년)에 중심 정맥 카테터 시장의 매출 성장을 초래할 것으로 예측됩니다.
중심 정맥 카테터 시장 역학
중심 정맥 카테터 시장의 주목할 만한 촉진요인 중 하나는 암, 심혈관질환, 신장병 등 만성질환의 유병률 증가입니다.
심부전, 뇌졸중 등 심혈관 질환의 유병률은 연령, 비만 등 다양한 요인으로 인해 전 세계에서 증가하고 있으며, 시장 확대가 예상됩니다. 예를 들어 세계보건기구(WHO)(2022)에 따르면 2019년 심혈관 질환(CVD)은 전 세계 주요 사망 원인 중 하나였으며, 2019년 약 1,790만 명이 CVD로 사망한 것으로 추정되며, 이는 전 세계 사망자의 32%에 해당합니다. 이는 사망률을 낮추는 심장 수술에 대한 수요가 증가하고 있음을 나타내며, 이는 중심정맥 카테터의 사용과 수요 증가로 이어져 시장에 긍정적인 영향을 미치고 있습니다.
중심정맥카테터가 주로 환자에게 화학요법 및 기타 약물을 투여하는 데 사용되는 다양한 유형의 암의 유병률 증가는 중심정맥카테터 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 세계보건기구(WHO) 데이터에 따르면 2020년 전 세계에서 유방암 226만 건, 폐암 221만 건, 대장암 193만 건, 전립선암 141만 건, 위암 109만 건이 보고되었습니다.
또한 암, 심혈관 질환 등 대부분의 만성질환의 위험 요인 중 하나가 노화이기 때문에 노인 환자의 부담이 증가하면 만성질환의 유병률이 높아질 수 있습니다. 예를 들어 WHO(2022)에 따르면 2030년까지 전 세계 인구 6명 중 1명이 60세 이상의 노인이 될 것이며, 2050년까지 전 세계 60세 이상 인구는 두 배로 늘어날 것으로 예상됩니다. 따라서 전 세계에서 노인 인구가 증가함에 따라 예측 기간 중 중앙 정맥 카테터 시장에 대한 수요가 증가 할 수 있습니다.
그러나 중심정맥카테터 리콜 건수 증가와 중심정맥카테터 시장과 관련된 감염성 질환은 중심정맥카테터 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
심장 정맥 카테터 시장은 COVID-19의 확산을 막기 위해 필요한 조치로 시행된 봉쇄 조치로 인해 시장 성장의 단기적인 억제가보고되었으며, COVID-19 전염병으로 인해 의료 서비스의 대규모 재편과 의료 절차의 시행이 이루어졌습니다. 많은 국가에서 COVID-19 위기 동안 워크플로우를 간소화하기 위해 응급의료의 필요성에 따라 의료 절차를 분리하고 심혈관 및 기타 수술, 화학요법을 포함한 다양한 의료 절차 및 기타 선택적이라고 간주되는 기타 의료 절차가 중단되어 시장 감소로 이어졌습니다. 그러나 의료 부문을 포함한 산업 전반의 활동이 재개되면서 2024-2030년의 예측 기간 중 중심정맥 카테터 시장은 상승세를 보이고 있습니다.
심장 정맥 카테터 시장 부문 분석
중심정맥카테터 시장의 제품 유형 부문에서는 터널형 중심정맥카테터가 예측 기간(2024-2030년) 동안 중심정맥카테터 시장에서 상당한 매출 성장을 기록할 것으로 예측됩니다.
이러한 배경에는 터널형 중심정맥 카테터와 관련된 여러 가지 용도와 장점이 있습니다. 터널형 중심정맥 카테터의 주요 장점은 거의 100%의 환자에서 작동하기 때문에 다재다능하며, 여러 부위에 삽입할 수 있다는 점입니다.
또한 이 카테터는 피하를 통과하여 다른 출구로 연결되기 때문에 안정성이 높아 비경구 영양, 수액 소생술, 항생제, 화학요법, 혈액 투석 등 장기적인 정맥 접근에 유리합니다. 또한 터널형 카테터를 삽입한 후에도 환자는 퇴원 후에도 몇 주에서 몇 달 동안 정맥내 치료를 계속 받을 수 있습니다.
터널형 중심정맥카테터는 정맥 내에서 매우 안전한 것으로 알려져 있으며, 보다 간단한 방법으로 정맥내 치료를 할 수 있으며, 환자의 불편함을 줄이고 수용성을 높일 수 있습니다.
세계의 중심 정맥 카테터 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품 개요 등을 제공하고 있습니다.
CENTRAL VENOUS CATHETERS MARKET BY PRODUCT TYPE (TUNNELED CENTRAL VENOUS CATHETERS AND NON-TUNNELED CENTRAL VENOUS CATHETERS), BY DESIGN (SINGLE LUMEN CENTRAL VENOUS CATHETERS, DOUBLE LUMEN CENTRAL VENOUS CATHETERS, AND MULTIPLE CENTRAL VENOUS CATHETERS), BY PLACEMENT SITE (INTERNAL JUGULAR VEIN, FEMORAL VEIN, AND SUBCLAVIAN VEIN) BY END-USER (HOSPTIALS AND CLINICS, AMBULATORY SURGICAL CENTERS, AND OTHERS) BY GEOGRAPHY IS ESTIMATED TO REGISTER GROWTH AT A REMARKABLE CAGR FORECAST DURING 2024-2030 OWING TO SURGE IN PREVALENCE OF CHRONIC DISEASES AND RISING NUMBER OF BLOOD TRANSFUSIONS.
The global central venous catheters market was valued at USD 2.73 billion in 2023, growing at a CAGR of 6.85% during the forecast period from 2024 to 2030 to reach USD 4.04 billion by 2030. The central venous catheters market is slated to witness prosperity owing to factors such as growing prevalence of chronic diseases such as cancer, cardiovascular and kidney diseases among others, increasing sedentary lifestyle, rising number of blood transfusions, and rising number of technological advancements with respect to the products are further expected to result in the appreciable revenue growth in the central venous catheters market during the forecast period (2024-2030).
CENTRAL VENOUS CATHETERS MARKET DYNAMICS:
One of the noteworthy drivers of the central venous catheters market is the rising prevalence of chronic diseases such as cancer, cardiovascular, and kidney diseases among others.
The increasing prevalence of cardiovascular disorders such as heart failure and stroke worldwide due to various factors such as, age, obesity, and others are anticipated to bolster the market. For instance, according to World Health Organization (WHO) 2022, in 2019, cardiovascular diseases (CVDs) was one of the leading cause of death globally. It was estimated that around 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. This indicates the growing need of cardiac surgeries to decrease the mortality rates, further leading to increase in the usage and demand of central venous catheters, positively impacting its market.
The rise in the prevalence of different cancer types where central venous catheters are largely used for providing chemotherapy, and other drugs to patients is going to positively impact the central venous catheters market. As per the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases colon and rectum, 1.41 million cases of prostate, and 1.09 million cases stomach cancer were reported in year 2020.
Moreover, the rising burden of the geriatric patients may increase the prevalence of chronic disorders as age is one of the risk factor for most of the chronic ailments including cancer, cardiovascular, and others. For instance, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or over. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). Thus, the increasing number of geriatric patients globally, may increase the demand of the central venous catheters market during the forecast period.
However, rising number of central venous catheter recalls and infections that are associated with central venous catheters market may act as restraining factors to the central venous catheters market growth.
The central venous catheters market reported a short period of restraint in market growth due to the implementation of lockdown as necessary measures to stop the spread of the COVID- 19 infection. The COVID- 19 pandemic resulted in the massive reorganization of the healthcare services and carrying out medical procedures. Many countries segregated medical procedures based on the need for urgent medical care in order to streamline the workflow during the COVID-19 crisis and saw various medical procedures including cardiovascular and other surgeries, chemotherapy sessions, and others considered elective being suspended, therefore leading to decline in the market. However, with the resumption of activities across industries including the healthcare sector, it has been uplifting for the central venous catheters market during the forecast period from 2024-2030.
CENTRAL VENOUS CATHETERS MARKET SEGMENT ANALYSIS:
Central venous catheters market by Product Type (Tunneled Central Venous Catheters and Non-Tunneled Central Venous Catheters), Design (Single Lumen Central Venous Catheters, Double Lumen Central Venous Catheters, and Multiple Central Venous Catheters), Placement Site (Internal Jugular Vein, Femoral Vein, and Subclavian Vein) End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others) Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Based on the product type segment of the central venous catheters market, the tunneled central venous catheters is projected to register a significant growth in revenue in the central venous catheters market during the forecast period (2024-2030).
This can be attributed to the multiple applications and advantages associated with the tunneled central venous catheters. Some of the major advantages of tunneled central venous catheters include its universal applicability as it is functional in nearly 100% of patients, and it can be inserted at multiple sites among others.
Also, these catheters are passed under the skin to a separate exit point which stabilizes them and make them advantageous for the long term therapies such as in case of providing long-term intravenous access for parenteral nutrition, fluid resuscitation, antibiotics, chemotherapy, and hemodialysis. Moreover, patients can continue to receive intravenous therapy upon their discharge from the hospital even after the placement of tunneled catheters for weeks to months.
Tunneled central venous catheters are known to be very secure in the vein, and can be utilized for giving IV therapy in an easier manner, thus reduces discomfort in patients and increases its acceptability.
These catheter also prevents other complications such as burning sensation, and others that happen while getting drugs by other IV methods.
Hence, owing to the various advantages associated with tunneled central venous catheters and its application in multiple indications, the product category is expected to witness a considerable growth eventually contributing to the overall growth of the global central venous catheters market during the forecast period.
NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL CENTRAL VENOUS CATHETERS MARKET:
Among all the regions, North America is expected to lead in revenue generation in the global central venous catheters market. This can be ascribed to the rising prevalence of different cancer types, rise in blood transfusion, and the rising approvals and launch of central venous catheters, particularly in the United States.
One of the key supporting factors for the growth of the North America central venous catheters market is the increasing prevalence of cancers in the United States. As per the figures mentioned by the American Cancer Society 2022, it was estimated that 1.9 million new cancer cases have been diagnosed in the United States in the year 2023. Also, according to the data provided by the Centers for Disease Control and Prevention (CDC) 2022, around 1,752,735 new cases of cancer were reported in the US in 2019.
Also, the rising cases of kidney diseases in the region is likely to increase the market growth for central venous catheters. As per the Centers for Disease Control and Prevention (CDC) 2022, around 37 million people have chronic kidney disease (CKD) in the US. The central venous catheters are used for the purpose of haemodialysis (HD) access.
Another important factor responsible for accelerating the US central venous catheters market is the rise in life saving blood transfusion procedures. For instance, according to the Centers for Disease Control and Prevention 2020, there are around 13.2 million blood donors in the United States, which results in a total of 17.2 million transfused blood product units per year.
Therefore, with the presence of large patient pool and major key players of central venous catheters market in the country, the demand for central venous catheters market is going to increase during the forecast period.
CENTRAL VENOUS CATHETERS MARKET KEY PLAYERS:
Some of the key market players operating in the central venous catheters market includes B. Braun Melsungen AG, ZOLL Medical Corporation, VOGT Medical, Insung Medical, Cook Group, Lepu Medical Technology Co., Ltd, Teleflex Incorporated, Poly Medicure Ltd., ICU Medical Inc., Becton, Dickinson and Company, Edwards Lifesciences Corporation, Vygon, Kimal, Medline Industries, LP, Medical Components, Inc., Medtronic, Prunus Medical, Merit Medical Systems, SCW Medicath Ltd, Prodimed, and others.
RECENT DEVELOPMENTAL ACTIVITIES IN CENTRAL VENOUS CATHETERS MARKET:
In March 2022, CorMedix Inc., announced that the resubmission of the New Drug Application (NDA) of DefenCath has been accepted for filing by the U.S. Food and Drug Administration (FDA). DefenCath is indicated for the reduction of catheter-related bloodstream infections (CRBSIs) in patients with renal failure who are receiving chronic hemodialysis via a central venous catheter.
In February 2022, Piccolo Medical received the US FDA clearance of its SmartPICC(TM) System which is used for navigating the positioning of peripherally inserted central catheters.
In March 2020, Access Vascular, Inc. received the US Food and Drug Administration (FDA) clearance for the second generation of its HydroPICCTM peripherally inserted central catheter (PICC).
KEY TAKEAWAYS FROM THE CENTRAL VENOUS CATHETERS MARKET REPORT STUDY
TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS CENTRAL VENOUS CATHETERS MARKET REPORT STUDY
FREQUENTLY ASKED QUESTIONS FOR CENTRAL VENOUS CATHETERS MARKET:
Central venous catheters is basically a long, soft, thin, hollow tube that is placed in a large (central) vein in the neck, upper chest or groin region and is used for the delivery of IV medications over a longer period of time.
The global central venous catheters market was valued at USD 2.73 billion in 2023, growing at a CAGR of 6.85% during the forecast period from 2024 to 2030 to reach USD 4.04 billion by 2030.
The central venous catheters market is slated to witness prosperity owing to factors such as growing prevalence of chronic diseases such as cancer, cardiovascular, and kidney diseases among others, increasing sedentary lifestyle, growing aging population base which is susceptible to the development of multiple diseases, and the growing focus on improving the safety and usability of central venous catheters for end users are further expected to result in the appreciable revenue growth in the central venous catheters market during the forecast period (2024-2030).
Some of the key market players operating in the central venous catheters market includes B. Braun Melsungen AG, ZOLL Medical Corporation, VOGT Medical, Insung Medical, Cook Group, Lepu Medical Technology Co., Ltd, Teleflex Incorporated, Poly Medicure Ltd., ICU Medical Inc., Becton, Dickinson and Company, Edwards Lifesciences Corporation, Vygon, Kimal, Medline Industries, LP, Medical Components, Inc., Medtronic, Prunus Medical, Merit Medical Systems, SCW Medicath Ltd, Prodimed, and others.
North America is expected to dominate the overall central venous catheters market during the forecast period, 2024 to 2030. This can be ascribed to the presence of large patient pool associated with cancer, kidney, and other diseases, increase in blood transfusion, high consumer awareness regarding new market launches and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.